Target Price | €26.39 |
Price | €19.26 |
Potential | 37.01% |
Number of Estimates | 18 |
18 Analysts have issued a price target Bayer 2025 . The average Bayer target price is €26.39. This is 37.01% higher than the current stock price. The highest price target is €37.00 92.11% , the lowest is €22.00 14.23% . | |
A rating was issued by 20 analysts: 4 Analysts recommend Bayer to buy, 16 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bayer stock has an average upside potential 2025 of 37.01% . Most analysts recommend the Bayer stock at Hold. |
17 Analysts have issued a sales forecast Bayer 2024 . The average Bayer sales estimate is €46.4b . This is 0.74% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €47.5b 1.73% , the lowest is €45.8b 2.12% .
This results in the following potential growth metrics:
2023 | €47.6b | 6.11% |
---|---|---|
2024 | €46.4b | 2.61% |
2025 | €46.7b | 0.56% |
2026 | €47.5b | 1.88% |
2027 | €48.2b | 1.34% |
2028 | €49.3b | 2.28% |
17 Analysts have issued an Bayer EBITDA forecast 2024. The average Bayer EBITDA estimate is €10.2b . This is 8.50% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €10.9b 2.06% , the lowest is €9.9b 10.50% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | €12.3b | 1.26% |
---|---|---|
2024 | €10.2b | 17.63% |
2025 | €9.8b | 3.22% |
2026 | €10.3b | 4.43% |
2027 | €10.2b | 0.69% |
2028 | €11.0b | 7.70% |
2023 | 25.91% | 7.86% |
---|---|---|
2024 | 21.91% | 15.43% |
2025 | 21.09% | 3.74% |
2026 | 21.62% | 2.51% |
2027 | 21.18% | 2.04% |
2028 | 22.30% | 5.29% |
7 Bayer Analysts have issued a net profit forecast 2024. The average Bayer net profit estimate is €2.3b . This is 359.89% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €3.6b 512.22% , the lowest is €1.6b 285.83% .
This results in the following potential growth metrics and future Net Margins:
2023 | €-2.9b | 170.85% |
---|---|---|
2024 | €2.3b | 178.23% |
2025 | €2.5b | 8.90% |
2026 | €2.9b | 15.99% |
2027 | €3.4b | 17.56% |
2028 | €3.8b | 12.71% |
2023 | -6.17% | 175.47% |
---|---|---|
2024 | 4.95% | 180.28% |
2025 | 5.36% | 8.28% |
2026 | 6.11% | 13.99% |
2027 | 7.08% | 15.88% |
2028 | 7.81% | 10.31% |
7 Analysts have issued a Bayer forecast for earnings per share. The average Bayer <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is €2.34 . This is 360.00% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is €3.71 512.22% , the lowest is €1.67 285.56% .
This results in the following potential growth metrics and future valuations:
2023 | €-2.99 | 170.85% |
---|---|---|
2024 | €2.34 | 178.26% |
2025 | €2.55 | 8.97% |
2026 | €2.95 | 15.69% |
2027 | €3.47 | 17.63% |
2028 | €3.91 | 12.68% |
Current | -21.50 | 158.10% |
---|---|---|
2024 | 8.23 | 138.28% |
2025 | 7.56 | 8.14% |
2026 | 6.52 | 13.76% |
2027 | 5.55 | 14.88% |
2028 | 4.92 | 11.35% |
Based on analysts' sales estimates for 2024, the Bayer stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 1.20 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 0.41 .
This results in the following potential growth metrics and future valuations:
Current | 1.19 | 20.13% |
---|---|---|
2024 | 1.20 | 0.71% |
2025 | 1.19 | 0.55% |
2026 | 1.17 | 1.85% |
2027 | 1.15 | 1.32% |
2028 | 1.13 | 2.24% |
Current | 0.40 | 36.72% |
---|---|---|
2024 | 0.41 | 0.74% |
2025 | 0.41 | 0.54% |
2026 | 0.40 | 1.85% |
2027 | 0.39 | 1.33% |
2028 | 0.38 | 2.21% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.